Robert Lewandowski, MD
Vascular & Interventional Radiology · Chicago, ILNPI 1689618761
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $733,101 of the $953,980 with a category attached, or 76.8%. 29 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 33.4% of the total. 2025 is the largest year on record at $335,617, 4.1 times the $81,309 reported in 2019. Among vascular & interventional radiology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 418 payments — averaging $2282.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$318K
- Trisalus Life Sciences, Inc.$261K
- Boston Scientific$142K
- Biocompatibles, Inc.$62K
- ABK Biomedical USA, Inc.$31K
- Siemens Medical Solutions USA, Inc.$31K
- plus $108K from 23 others
Across 18 payments — averaging $20,090 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$145K
- Siemens Medical Solutions USA, Inc.$98K
- Instylla, Inc.$60K
- Boston Scientific$43K
- Bard Peripheral Vascular, Inc.$9K
- ABK Biomedical USA, Inc.$6K
Across 3 payments — averaging $1400.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Shape Memory Medical Inc.$4K
- ABK Biomedical USA, Inc.$0
What the payments were for
- Consulting fees$733,10177%
- Speaking & faculty fees$121,81813%
- Grants$8000%
- Travel & lodging$84,7529%
- Food & beverage$11,5311%
- Education$1,9780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 114 | $318,315 |
| Trisalus Life Sciences, Inc. | 16 | $261,196 |
| Boston Scientific | 142 | $142,444 |
| Biocompatibles, Inc. | 17 | $62,243 |
| ABK Biomedical USA, Inc. | 15 | $31,163 |
| Siemens Medical Solutions USA, Inc. | 16 | $30,918 |
| AstraZeneca | 19 | $27,101 |
| Delcath Systems | 12 | $21,585 |
| Eisai Inc. | 3 | $12,800 |
| Varian Medical Systems, Inc. | 6 | $12,347 |
| Incyte Corporation | 8 | $7,231 |
| Astrazeneca UK Limited | 1 | $5,370 |
| Sirtex Medical Inc | 14 | $4,242 |
| E.r. Squibb & Sons, L.L.C. | 2 | $3,013 |
| Medtronic | 11 | $2,825 |
| Merck | 1 | $2,440 |
| Terumo Medical Corporation | 5 | $2,175 |
| Genentech USA, Inc. | 2 | $1,995 |
| Fujifilm Healthcare Americas Corporation | 3 | $1,356 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $1,300 |
| Philips North America LLC | 1 | $900 |
| Shape Memory Medical Inc. | 2 | $629 |
| Inari Medical, Inc. | 1 | $138 |
| BTG International Canada Inc. | 1 | $125 |
| Davol Inc. | 1 | $53 |
| Cook Medical LLC | 1 | $19 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Argon Medical Devices, Inc. | 1 | $19 |
| Penumbra, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINAV INFUSION SYSTEM$261,137
- THERASPHERE-BIO$62,238
- TheraSphere Y90 Glass Microspheres 10 GBq$41,125
- Eye90 microspheres$30,423
- GENERAL - THERAPIES$29,823
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$26,469
- Hepzato Kit$21,450
- IMFINZI$17,526
- LENVIMA$12,800
- GENERAL - IO ABLATION$8,750
- General - Interventional Oncology$8,142
- GENERAL PAIN MANAGEMENT$8,000
- SIR-Spheres Microspheres$4,074
- ANGIOJET$3,619
- GENERAL VASCULAR INTERVENTION$2,625
- TECENTRIQ$1,995
- Navicross$1,825
- CONCERTOTM$1,250
- uTASWako AFP-L3$1,125
- GlideLight$900
How this compares
$953,980 in reported general payments places this provider in the 95th percentile of 197 vascular & interventional radiology providers in Illinois.
See all vascular & interventional radiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Chicago
- Riad SalemChicago$2.3M
- Kush DesaiChicago$1M
- Christopher MolvarChicago$850K
- Sreekumar MadasseryChicago$459K
- Bulent ArslanChicago$300K
- Sameer AnsariChicago$161K
- Ahsun RiazChicago$127K
- Ramona GuptaChicago$72K
- Scott ResnickChicago$38K
- Erica AlexanderChicago$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.